Adiposity patterns and the risk for ESRD in postmenopausal women

Clinical Journal of the American Society of Nephrology

Volumn 10, Issue 2, 2015, Pages 241-250

  Franceschini, Nora ^a   Gouskova, Natalia A ^a   Reiner, Alex P ^b   Bostom, Andrew ^c   Howard, Barbara V ^d,e   Pettinger, Mary ^f   Umans, Jason G ^d,e   Brookhart, M Alan ^a   Winkelmayer, Wolfgang C ^g   Eaton, Charles B ^c   Heiss, Gerardo ^a   Fine, Jason P ^a  

^a University of North Carolina at Chapel Hill   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c BROWN UNIVERSITY   (United States)

^d MEDSTAR RESEARCH INSTITUTE   (United States)

^e Delaware   (United States)

^f USA   (United States)

^g BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DEATH; DIABETES MELLITUS; DISEASE ASSOCIATION; END STAGE RENAL DISEASE; ETHNICITY; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; MORTALITY; OBESITY; POSTMENOPAUSE; PROSPECTIVE STUDY; WAIST CIRCUMFERENCE; AFRICAN AMERICAN; CAUCASIAN; COMPARATIVE STUDY; EPIDEMIOLOGY; ETHNOLOGY; HISPANIC; INCIDENCE; KIDNEY; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; OBESITY, ABDOMINAL; PATHOPHYSIOLOGY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; TIME FACTOR; UNITED STATES;

ADIPOSITY; AFRICAN AMERICANS; AGED; BODY MASS INDEX; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HISPANIC AMERICANS; HUMANS; INCIDENCE; KIDNEY; KIDNEY FAILURE, CHRONIC; MIDDLE AGED; OBESITY, ABDOMINAL; POSTMENOPAUSE; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; UNITED STATES; WAIST CIRCUMFERENCE;

EID: 84923765379     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.02860314     Document Type: Article

References (48)

1. Tanner RM, Brown TM, Muntner P: Epidemiology of obesity, the metabolic syndrome, and chronic kidney disease. Curr Hypertens Rep 14: 152–159, 2012.
2. Hsu CY, McCulloch CE, Iribarren C, Darbinian J, Go AS: Body mass index and risk for end-stage renal disease. Ann Intern Med 144: 21–28, 2006.
3. Reynolds K, Gu D, Muntner P, Chen J, Wu X, Yau CL, Duan X, Chen CS, Hamm LL, He J: Body mass index and risk of ESRD in China. Am J Kidney Dis 50: 754–764, 2007.
4. Collins AJ, Foley RN, Chavers B, Gilbertson D, Herzog C, Johansen K, Kasiske B, Kutner N, Liu J, St Peter W, Guo H, Gustafson S, Heubner B, Lamb K, Li S, Peng Y, Qiu Y, Roberts T, Skeans M, Snyder J, Solid C, Thompson B, Wang C, Weinhandl E, Zaun D, Arko C, Chen SC, Daniels F, Ebben J, Frazier E, Hanzlik C, Johnson R, Sheets D, Wang X, Forrest B, Constantini E, Everson S, Eggers P, Agodoa L: United States Renal Data System 2011 Annual Data Report: Atlas of chronic kidney disease & end-stage renal disease in the United States. AmJ Kidney Dis 59[1 Suppl 1]: e1–e420, 2012.
5. Xue JL, Eggers PW, Agodoa LY, Foley RN, Collins AJ: Longitudinal study of racial and ethnic differences in developing end-stage renal disease among aged medicare beneficiaries. J Am Soc Nephrol 18: 1299–1306, 2007.
6. Peralta CA, Shlipak MG, Fan D, Ordoñez J, Lash JP, Chertow GM, Go AS: Risks for end-stage renal disease, cardiovascular events, and death in Hispanic versus non-Hispanic white adults with chronic kidney disease. J Am Soc Nephrol 17: 2892–2899, 2006.
7. Sarnak MJ: Cardiovascular complications in chronic kidney disease. Am J Kidney Dis 41[Suppl]: 11–17, 2003.
8. Shidler NR, Peterson RA, Kimmel PL: Quality of life and psychosocial relationships in patients with chronic renal insufficiency. Am J Kidney Dis 32: 557–566, 1998.
9. Hunsicker LG: The consequences and costs of chronic kidney disease before ESRD. J Am Soc Nephrol 15: 1363–1364, 2004.
10. Kurella M, Covinsky KE, Collins AJ, Chertow GM: Octogenarians and nonagenarians starting dialysis in the United States. Ann Intern Med 146: 177–183, 2007.
11. Toth MJ, Tchernof A, Sites CK, Poehlman ET: Menopause-related changes inbody fat distribution. AnnNYAcad Sci 904:502–506,2000.
12. Port FK, Ashby VB, Dhingra RK, Roys EC, Wolfe RA: Dialysis dose and body mass index are strongly associated with survival in hemodialysis patients. J Am Soc Nephrol 13: 1061–1066, 2002.
13. Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS, Jadbabaie F, Kosiborod M, Portnay EL, Sokol SI, Bader F, Krumholz HM: The obesity paradox: Body mass index and outcomes in patients with heart failure. Arch Intern Med 165: 55–61, 2005.
14. Rüster C, Wolf G: Adipokines promote chronic kidney disease. Nephrol Dial Transplant 28[Suppl 4]: iv8–iv14, 2013.
15. Yamahara K, Kume S, Koya D, Tanaka Y, Morita Y, Chin-Kanasaki M, Araki H, Isshiki K, Araki S, Haneda M, Matsusaka T, Kashiwagi A, Maegawa H, Uzu T: Obesity-mediated autophagy insufficiency exacerbates proteinuria-induced tubulointerstitial lesions. J Am Soc Nephrol 24: 1769–1781, 2013.
16. Fox CS, Larson MG, Leip EP, Culleton B, Wilson PW, Levy D: Predictors of new-onset kidney disease in a community-based population. JAMA 291: 844–850, 2004.
17. Munkhaugen J, Lydersen S, Widerøe TE, Hallan S: Prehypertension, obesity, and risk of kidney disease: 20-year followup of theHUNT I study in Norway. AmJ KidneyDis 54: 638–646, 2009.
18. Muntner P, Winston J, Uribarri J, Mann D, Fox CS: Overweight, obesity, and elevated serum cystatin C levels in adults in the United States. Am J Med 121: 341–348, 2008.
19. Knight EL, Verhave JC, Spiegelman D, Hillege HL, de Zeeuw D, Curhan GC, de Jong PE: Factors influencing serum cystatin C levels other than renal function and the impact on renal function measurement. Kidney Int 65: 1416–1421, 2004.
20. Noori N, Hosseinpanah F, Nasiri AA, Azizi F:Comparison of overall obesity and abdominal adiposity in predicting chronic kidney disease incidence among adults. J Ren Nutr 19: 228–237, 2009.
21. de Boer IH, Sibley SD, Kestenbaum B, Sampson JN, Young B, Cleary PA, Steffes MW, Weiss NS, Brunzell JD; Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Study Research Group: Central obesity, incident microalbuminuria, and change in creatinine clearance in the epidemiology of diabetes interventions and complications study. J Am Soc Nephrol 18: 235–243, 2007.
22. Thomas G, Sehgal AR, Kashyap SR, Srinivas TR, Kirwan JP, Navaneethan SD: Metabolic syndrome and kidney disease: A systematic review and meta-analysis. Clin J Am Soc Nephrol 6: 2364–2373, 2011.
23. Perry HM Jr., Miller JP, Fornoff JR, Baty JD, Sambhi MP, Rutan G, Moskowitz DW, Carmody SE: Early predictors of 15-year endstage renal disease in hypertensive patients. Hypertension 25: 587–594, 1995.
24. The Women’s Health Initiative Study Group: Design of the Women’s Health Initiative clinical trial and observational study. Control Clin Trials 19: 61–109, 1998.
25. National Institutes of Health: Clinical Guidelines on the Identi- fication, Evaluation and Treatment of Overweight and Obesity in Adults: The Evidence Report, NIH Publication No. 98-4083, Bethesda, MD, National Institutes of Health, 1998.
26. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr., Jones DW, Materson BJ, Oparil S, Wright JT Jr., Roccella EJ; Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. National Heart, Lung, and Blood Institute; National High Blood Pressure Education Program Coordinating Committee: Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 42: 1206–1252, 2003.
27. Levey AS, Stevens LA: Estimating GFR using the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation: More accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions. Am J Kidney Dis 55: 622–627, 2010.
28. USRDS: The United States Renal Data System. Am J Kidney Dis 42[Suppl 5]: 1–230, 2003.
29. Curb JD, McTiernan A, Heckbert SR, Kooperberg C, Stanford J, Nevitt M, Johnson KC, Proulx-Burns L, Pastore L, Criqui M, Daugherty S; WHI Morbidity and Mortality Committee: Outcomes ascertainment and adjudication methods in theWomen’s Health Initiative. Ann Epidemiol 13[Suppl]: S122–S128, 2003.
30. Pepe MS, Mori M: Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data? Stat Med 12: 737–751, 1993.
31. Gray RJ: A class of K-sample tests for comparing the cumulative incidence of a competing risks. Ann Stat 16: 1141–1154, 1988.
32. Fine JP, Gray RJ: A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 446: 496–509, 1999.
33. Prentice RL, Kalbfleisch JD, Peterson AV Jr., Flournoy N, Farewell VT, Breslow NE: The analysis of failure times in the presence of competing risks. Biometrics 34: 541–554, 1978.
34. Bash LD, Astor BC, Coresh J: Risk of incident ESRD: A comprehensive look at cardiovascular risk factors and 17 years of followup in the Atherosclerosis Risk in Communities (ARIC) Study. Am J Kidney Dis 55: 31–41, 2010.
35. Hsu CY, Iribarren C, McCulloch CE, Darbinian J, Go AS: Risk factors for end-stage renal disease: 25-year follow-up. Arch Intern Med 169: 342–350, 2009.
36. Elsayed EF, Sarnak MJ, Tighiouart H, Griffith JL, Kurth T, Salem DN, Levey AS, Weiner DE: Waist-to-hip ratio, body mass index, and subsequent kidney disease and death. Am J Kidney Dis 52: 29–38, 2008.
37. Ejerblad E, Fored CM, Lindblad P, Fryzek J, McLaughlin JK, Nyrén O: Obesity and risk for chronic renal failure. J Am Soc Nephrol 17: 1695–1702, 2006.
38. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults: Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: Executive summary. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults. Am J Clin Nutr 68: 899–917, 1998.
39. Molarius A, Seidell JC: Selection of anthropometric indicators for classification of abdominal fatness—a critical review. Int J Obes Relat Metab Disord 22: 719–727, 1998.
40. Pouliot MC, Després JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A, Nadeau A, Lupien PJ: Waist circumference and abdominal sagittal diameter: Best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 73: 460–468, 1994.
41. Després JP, Prud’homme D, Pouliot MC, Tremblay A, Bouchard C: Estimation of deep abdominal adipose-tissue accumulation from simple anthropometric measurements in men. Am J Clin Nutr 54: 471–477, 1991.
42. Nicklas BJ, Cesari M, Penninx BW, Kritchevsky SB, Ding J, Newman A, Kitzman DW, Kanaya AM, Pahor M, Harris TB: Abdominal obesity is an independent risk factor for chronic heart failure in older people. J Am Geriatr Soc 54: 413–420, 2006.
43. Loehr LR, Rosamond WD, Poole C, McNeill AM, Chang PP, Folsom AR, Chambless LE, Heiss G: Association of multiple anthropometrics of overweight and obesity with incident heart failure: The Atherosclerosis Risk in Communities study. Circ Heart Fail 2: 18–24, 2009.
44. Taylor AE, Ebrahim S, Ben-Shlomo Y, Martin RM, Whincup PH, Yarnell JW, Wannamethee SG, Lawlor DA: Comparison of the associations of body mass index and measures of central adiposity and fat masswith coronary heart disease, diabetes, and allcause mortality: A study using data from 4 UK cohorts. Am J Clin Nutr 91: 547–556, 2010.
45. Vazquez G, Duval S, Jacobs DR Jr., Silventoinen K: Comparison of body mass index, waist circumference, and waist/hip ratio in predicting incident diabetes: A meta-analysis. Epidemiol Rev 29: 115–128, 2007.
46. Canoy D, Boekholdt SM, Wareham N, Luben R, Welch A, Bingham S, Buchan I, Day N, Khaw KT: Body fat distribution and risk of coronary heart disease in men and women in the European Prospective Investigation Into Cancer and Nutrition in Norfolk cohort: A population-based prospective study. Circulation 116: 2933–2943, 2007.
47. Folsom AR, Kushi LH, Anderson KE, Mink PJ, Olson JE, Hong CP, Sellers TA, Lazovich D, Prineas RJ: Associations of general and abdominal obesity with multiple health outcomes in older women: The IowaWomen’s Health Study. Arch Intern Med 160: 2117–2128, 2000.
48. Pischon T, Boeing H, Hoffmann K, Bergmann M, Schulze MB, Overvad K, van der Schouw YT, Spencer E, Moons KG, Tjønneland A, Halkjaer J, Jensen MK, Stegger J, Clavel-Chapelon F, Boutron-Ruault MC, Chajes V, Linseisen J, Kaaks R, Trichopoulou A, Trichopoulos D, Bamia C, Sieri S, Palli D, Tumino R, Vineis P, Panico S, Peeters PH, May AM, Buenode- Mesquita HB, van Duijnhoven FJ, Hallmans G, Weinehall L, Manjer J, Hedblad B, Lund E, Agudo A, Arriola L, Barricarte A, Navarro C, Martinez C, Quirós JR, Key T, Bingham S, Khaw KT, Boffetta P, Jenab M, Ferrari P, Riboli E: General and abdominal adiposity and risk of death in Europe. N Engl J Med 359: 2105–2120, 2008.